81001041/National Natural Science Foundation of China[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2022	3
2023	1
2025	0

Page 1

IGSF11 and VISTA: a pair of promising immune checkpoints in tumor immunotherapy.

Tang XY, Xiong YL, Shi XG, Zhao YB, Shi AP, Zheng KF, Liu YJ, Jiang T, Ma N, Zhao JB. Tang XY, et al. Biomark Res. 2022 Jul 13;10(1):49. doi: 10.1186/s40364-022-00394-0. Biomark Res. 2022. PMID: 35831836 Free PMC article. Review.

Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model.

Qiao T, Zhao J, Xin X, Xiong Y, Guo W, Meng F, Li H, Feng Y, Xu H, Shi C, Han Y. Qiao T, et al. Cancer Immunol Immunother. 2023 May;72(5):1169-1181. doi: 10.1007/s00262-022-03318-x. Epub 2022 Nov 10. Cancer Immunol Immunother. 2023. PMID: 36357599 Free PMC article.

CD155 Cooperates with PD-1/PD-L1 to Promote Proliferation of Esophageal Squamous Cancer Cells via PI3K/Akt and MAPK Signaling Pathways.

Tang X, Yang J, Shi A, Xiong Y, Wen M, Luo Z, Tian H, Zheng K, Liu Y, Shu C, Ma N, Wang R, Zhao J. Tang X, et al. Cancers (Basel). 2022 Nov 15;14(22):5610. doi: 10.3390/cancers14225610. Cancers (Basel). 2022. PMID: 36428703 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year